These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14973540)

  • 1. Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors.
    Bastone P; Löchelt M
    Gene Ther; 2004 Mar; 11(5):465-73. PubMed ID: 14973540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
    Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M
    Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors.
    Liu W; Backes P; Löchelt M
    Virology; 2009 Nov; 394(2):208-17. PubMed ID: 19775717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bet gene of feline foamy virus is required for virus replication.
    Alke A; Schwantes A; Kido K; Flötenmeyer M; Flügel RM; Löchelt M
    Virology; 2001 Sep; 287(2):310-20. PubMed ID: 11531409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feline foamy virus-mediated marker gene transfer: identification of essential genetic elements and influence of truncated and chimeric proteins.
    Bastone P; Bravo IG; Löchelt M
    Virology; 2006 Apr; 348(1):190-9. PubMed ID: 16443252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells expressing the human foamy virus (HFV) accessory Bet protein are resistant to productive HFV superinfection.
    Bock M; Heinkelein M; Lindemann D; Rethwilm A
    Virology; 1998 Oct; 250(1):194-204. PubMed ID: 9770433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replicating foamy virus-based vectors directing high level expression of foreign genes.
    Schmidt M; Rethwilm A
    Virology; 1995 Jun; 210(1):167-78. PubMed ID: 7793069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and functional characterization of feline foamy virus-based retroviral vectors.
    Schwantes A; Ortlepp I; Löchelt M
    Virology; 2002 Sep; 301(1):53-63. PubMed ID: 12359446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
    Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
    J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
    Schambach A; Mueller D; Galla M; Verstegen MM; Wagemaker G; Loew R; Baum C; Bohne J
    Gene Ther; 2006 Nov; 13(21):1524-33. PubMed ID: 16763662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
    Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
    J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
    Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
    Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and analysis of genomic, full-length infectious foamy virus DNA clones.
    Wirtz R; Löchelt M
    Methods Mol Biol; 2005; 304():423-34. PubMed ID: 16061994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences.
    Zemba M; Alke A; Bodem J; Winkler IG; Flower RL; Pfrepper K; Delius H; Flügel RM; Löchelt M
    Virology; 2000 Jan; 266(1):150-6. PubMed ID: 10612669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foamy virus--adenovirus hybrid vectors.
    Picard-Maureau M; Kreppel F; Lindemann D; Juretzek T; Herchenröder O; Rethwilm A; Kochanek S; Heinkelein M
    Gene Ther; 2004 Apr; 11(8):722-8. PubMed ID: 14724670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors.
    Hlavaty J; Portsmouth D; Stracke A; Salmons B; Günzburg WH; Renner M
    Virology; 2004 Dec; 330(1):351-60. PubMed ID: 15527860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus.
    Alke A; Schwantes A; Zemba M; Flügel RM; Löchelt M
    Virology; 2000 Sep; 275(1):170-6. PubMed ID: 11017797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.